InflaRx N.V.
IFRX · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | -0.04 | 0.10 | -0.06 |
| FCF Yield | -16.67% | -23.50% | -8.48% | -11.94% |
| EV / EBITDA | -2.32 | -1.60 | -24.59 | -3.21 |
| Quality | ||||
| ROIC | -22.40% | -18.26% | -15.68% | -23.20% |
| Gross Margin | -5,985.37% | 0.00% | 666,984.16% | 158.60% |
| Cash Conversion Ratio | 0.74 | 0.52 | 1.69 | 2.33 |
| Growth | ||||
| Revenue 3-Year CAGR | 1.10% | 545,963.35% | 506,158.66% | 549,254.61% |
| Free Cash Flow Growth | 46.04% | -17.75% | -23.30% | 20.46% |
| Safety | ||||
| Net Debt / EBITDA | 0.87 | 5.68 | 3.52 | 1.46 |
| Interest Coverage | -3,850.37 | -3,182.85 | -2,042.99 | -3,052.47 |
| Efficiency | ||||
| Inventory Turnover | 0.48 | 0.00 | 0.41 | -0.01 |
| Cash Conversion Cycle | 3,826.34 | -14,249.59 | -369,363.67 | 4,153.10 |